CNR2 and Parkinson disease: Furthermore, studies outside the field of synucleinopathies, have observed that CB2 signaling can activate the PI3K/Akt and mammalian target of rapamycin (mTOR) pathways which is implicated in the autophagy-lysosome system and associated with PD progression [66, 67].